Refractory Lymphomas Recruiting Phase 1 / 2 Trials for Venetoclax (DB11581)

Also known as: Refractory Lymphoma

IndicationStatusPhase
DBCOND0042145 (Refractory Lymphomas)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04855695Avo In R/R And Previously Untreated MCLTreatment